EUVIMEDEUVIMED entdecken
Crossref

Lipid-Lowering Medications are Associated with Reduced Sarcopenia-Related Quality of Life in Older Adults with Hyperlipidemia

Rizwan Qaisar iD, Imran M Khan, Asima Karim, Tahir Muhammad, Firdos Ahmad

Drugs & Aging · 2024

DOI: 10.1007/s40266-024-01111-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drugs & Aging, 2024. Verfasst von Rizwan Qaisar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, M27-122, College of Medicine, University of Sharjah, 27272, Sharjah, United Arab Emirates. rqaisar@sharjah.ac.a…. Hauptthemen laut MEDLINE: Sarcopenia, Quality of Life, Hyperlipidemias, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: University of Sharjah.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Statins medications negatively affect age-associated loss of muscle mass and strength, termed sarcopenia, and neuromuscular junction (NMJ) integrity. However, their association with the sarcopenia-related-quality-of-life (SarQoL) is unknown. METHODS: In this cross-sectional, case control study, we recruited male nonusers (n = 75 and age 75.2 ± 5.9 years) and users (n = 77 and age 77.1 ± 6.2 years) of statins to evaluate SarQoL and handgrip strength (HGS). We also measured plasma C-terminal agrin fragment-22 (CAF22) as a marker of NMJ degradation. RESULTS: Statin users had higher CAF22, and lower HGS, and cumulative SarQoL scores than non-users (all p < 0.05). Plasma CAF22 exhibited negative correlations with SarQoL scores for physical and mental health, locomotion, functionality, activities-of-daily-living, and cumulative SarQoL in statins users and non-users (all p < 0.05). Lastly, the cumulative SarQoL scores exhibited positive associations with HGS and gait speed in the study participants (all p < 0.05). CONCLUSIONS: Collectively, statin usage was associated with NMJ degradation and reduced SarQoL. Statins should be cautiously prescribed in patients with sarcopenia with reduced QoL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaQuality of LifeHyperlipidemiasHydroxymethylglutaryl-CoA Reductase InhibitorsHumansMaleAgedCross-Sectional StudiesCase-Control StudiesHand StrengthAged, 80 and overHypolipidemic AgentsAgrin

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsAgrin

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, M27-122, College of Medicine, University of Sharjah, 27272, Sharjah, United Arab Emirates. rqaisar@sharjah.ac.ae.
  • Space Medicine Research Group, Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates. rqaisar@sharjah.ac.ae.
  • Cardiovascular Research Group, Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates. rqaisar@sharjah.ac.ae.
  • Burn and Plastic Surgery Center, Hayatabad Medical Complex, Hayatabad, Peshawar, Pakistan.
  • Department of Basic Medical Sciences, M27-122, College of Medicine, University of Sharjah, 27272, Sharjah, United Arab Emirates.
  • Iron Biology Research Group, Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.

ORCID-Profile: Rizwan Qaisar

Förderung

  • University of Sharjah

Zitieren

APA

Qaisar, R., Khan, I. M., Karim, A., Muhammad, T., & Ahmad, F. (2024). Lipid-Lowering Medications are Associated with Reduced Sarcopenia-Related Quality of Life in Older Adults with Hyperlipidemia. Drugs & Aging. https://doi.org/10.1007/s40266-024-01111-2

Vancouver

Qaisar R, Khan IM, Karim A, Muhammad T, Ahmad F. Lipid-Lowering Medications are Associated with Reduced Sarcopenia-Related Quality of Life in Older Adults with Hyperlipidemia. Drugs & Aging. 2024. doi:10.1007/s40266-024-01111-2

BibTeX
@article{Qaisar2024,
  author = {Qaisar, Rizwan and Khan, Imran M and Karim, Asima and Muhammad, Tahir and Ahmad, Firdos},
  title = {Lipid-Lowering Medications are Associated with Reduced Sarcopenia-Related Quality of Life in Older Adults with Hyperlipidemia},
  journal = {Drugs & Aging},
  year = {2024},
  doi = {10.1007/s40266-024-01111-2}
}
Kostenlos starten →